Colin Shannon - 17 Jun 2021 Form 4 Insider Report for PRA Health Sciences, Inc.

Role
President & CEO, Director
Signature
By: /s/ Christopher L. Gaenzle, by power of attorney
Issuer symbol
N/A
Transactions as of
17 Jun 2021
Net transactions value
-$54,012,748
Form type
4
Filing time
21 Jun 2021, 17:25:58 UTC
Previous filing
30 Jun 2021
Next filing
01 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRAH Common Stock Options Exercise $908,195 +77,425 +142% $11.73 132,051 17 Jun 2021 Direct
transaction PRAH Common Stock Options Exercise $1,947,602 +166,036 +126% $11.73 298,087 17 Jun 2021 Direct
transaction PRAH Common Stock Options Exercise $6,898,710 +91,000 +31% $75.81 389,087 17 Jun 2021 Direct
transaction PRAH Common Stock Options Exercise $2,974,140 +31,000 +8% $95.94 420,087 17 Jun 2021 Direct
transaction PRAH Common Stock Options Exercise $4,609,800 +45,000 +11% $102.44 465,087 17 Jun 2021 Direct
transaction PRAH Common Stock Options Exercise $3,282,874 +31,780 +6.8% $103.30 496,867 17 Jun 2021 Direct
transaction PRAH Common Stock Sale $153,539 -920 -0.19% $166.89 495,947 17 Jun 2021 Direct F1, F2
transaction PRAH Common Stock Sale $27,128,112 -161,352 -33% $168.13 334,595 17 Jun 2021 Direct F1, F3
transaction PRAH Common Stock Sale $37,212,955 -220,195 -66% $169.00 114,400 17 Jun 2021 Direct F1, F4
transaction PRAH Common Stock Sale $10,139,464 -59,774 -52% $169.63 54,626 17 Jun 2021 Direct F1, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRAH Stock Option (Right to Buy) Options Exercise $0 -77,425 -100% $0.000000* 0 17 Jun 2021 Common Stock 77,425 $11.73 Direct
transaction PRAH Stock Option (Right to Buy) Options Exercise $0 -166,036 -100% $0.000000* 0 17 Jun 2021 Common Stock 166,036 $11.73 Direct F6
transaction PRAH Stock Option (Right to Buy) Options Exercise $0 -91,000 -70% $0.000000 39,000 17 Jun 2021 Common Stock 91,000 $75.81 Direct F7
transaction PRAH Stock Option (Right to Buy) Options Exercise $0 -31,000 -33% $0.000000 62,000 17 Jun 2021 Common Stock 31,000 $95.94 Direct F8
transaction PRAH Stock Option (Right to Buy) Options Exercise $0 -45,000 -50% $0.000000 45,000 17 Jun 2021 Common Stock 45,000 $102.44 Direct F9
transaction PRAH Stock Option (Right to Buy) Options Exercise $0 -31,780 -33% $0.000000 63,560 17 Jun 2021 Common Stock 31,780 $103.30 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $166.43 to $167.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2), (3), (4) and (5) of this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $167.53 to $168.525, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $168.53 to $169.52, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $169.53 to $169.87, inclusive.
F6 The option vested in five equal annual installments, commencing on September 23, 2014
F7 The option vests in four annual installments, commencing on August 29, 2018 at 20% of the grant in the first two years and 30% of the grant in the remaining two years thereafter.
F8 The option vests in three equal annual installments of 31,000 beginning on August 13, 2020.
F9 The option vests in four equal annual installments of 22,500 beginning on August 16, 2019.
F10 The option vests in three equal annual installments of 31,780 beginning on June 1, 2021.